Article Details
Retrieved on: 2023-01-10 18:27:34
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
ASTRAZENECA yesterday said it had struck a deal to buy US-based drug developer Cincor Pharma for up to $1.8bn (£1.4bn) to increase its stock of ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here